208370.KQ Hana Must SPAC 2

Healthcare Health Care Equipment & Supplies KOSDAQ
2,110 KRW
Close of Oct 29, 2026
2,060 7,490
Market cap
KRW 54.3B
P/E
6.4x
P/B
0.72x
ROE
12.0%
Dividend yield
-
Fundamental score
2.7/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 208370.KQ undervalued?

Graham number
Price2,110
Graham value4,659
Discount54.7%

208370.KQ trades 54.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Hana Must SPAC 2 fundamental analysis

14 of 22 checks passed

ROE 1/2

Moderate return on equity (12.0%), between 10% and 20%.

ROA 1/1

Return on assets (10.7%) is above the industry median (6.2%).

Profit Consistency 2/2

Profitable for 6 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (23.4%) is not above the 5-year average (34.0% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (23.4%) is above the industry median (0.5%).

Revenue Growth 1/2

Revenue grew 3.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

EBIT is 123.2x against interest expense, well covered.

PE vs Market 1/1

PE (6.4x) is below the market median (11.3x).

PE vs Industry 1/1

PE (6.4x) is below the industry median (7.6x).

PBV 1/1

Price to book (0.7x) is below the industry median (0.7x).

Graham Number 1/1

The price is below the Graham number (PE x PB = 4.6, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.19, growth is cheap.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Hana Must SPAC 2 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Hana Must SPAC 2

SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers. Its products are us…

Full company profile